Bleeding after tooth extraction in patients taking aspirin and clopidogrel (Plavix®) compared with healthy controls

The risk of perioperative bleeding is high in patients who take aspirin and clopidogrel after a percutaneous coronary intervention, and whether to stop the drugs is a matter of concern for dentists. The aim of this study was to answer the specific question: should aspirin and clopidogrel bisulphate (Plavix®) be discontinued during a conventional forceps extraction? We studied 64 patients during the first year after percutaneous insertion of coronary stents who were taking aspirin (ASA) 80mg and clopidogrel (Plavix®) 75mg, and 50 healthy patients who were to have a conventional forceps extraction at this polyclinic in 2013-2014and acted as controls. (Source: The British Journal of Oral and Maxillofacial Surgery)
MedWorm: Dentistry